Filter
616
Filtered Results: 616
Text search:
rapide
confirmation
de
laboratoire
Featured
Recommendations
75
New Publications
165
Language
Document type
No document type
350
Guidelines
132
Studies & Reports
54
Manuals
31
Strategic & Response Plan
28
Training Material
8
Fact sheets
8
Situation Updates
5
Countries / Regions
Congo, Democratic Republic of
48
Senegal
31
Western and Central Europe
26
Africa
21
Eastern Europe
17
Burkina Faso
16
Global
16
Rwanda
15
Guinea
15
Mali
13
Benin
11
Cameroon
11
Latin America and the Carribbean
11
South Africa
11
Haiti
10
India
10
Côte d’Ivoire / Ivory Coast
9
Madagascar
9
Sierra Leone
8
Nigeria
8
West and Central Africa
8
Liberia
8
Niger
7
Tanzania
7
East and Southern Africa
7
Uganda
7
Togo
5
Central African Republic
5
Kenya
4
Ukraine
4
Malawi
4
South–East Asia Region
4
Chad
4
Zimbabwe
3
Western Pacific Region
3
Turkey
2
Ghana
2
Syria
2
Philippines
2
Mozambique
2
Middle East and North Africa
2
France
2
Brazil
2
Namibia
2
Ethiopia
2
Zambia
2
Nepal
1
Colombia
1
Timor Leste/ East Timor
1
Lesotho
1
Estonia
1
Afghanistan
1
Morocco
1
Mauritania
1
Guinea-Bissau
1
Germany
1
Eastern Europe and Central Asia
1
North America
1
Mauritius
1
United Kingdom
1
Portugal
1
Spain
1
Argentina
1
Vietnam
1
Yemen
1
Georgia
1
Myanmar / Burma
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
208
Clinical Guidelines
107
Public Health
40
Pharmacy & Technologies
28
Key Resources
17
Women & Child Health
11
Capacity Building
5
Toolboxes
Rapid Response
85
TB
72
COVID-19
69
Ebola
54
NTDs
36
HIV
33
Cholera
14
Zika
11
AMR
10
Polio
9
Pharmacy
8
Caregiver
7
Natural Hazards
6
Planetary Health
6
Conflict
5
Mental Health
3
NCDs
3
Specific Hazards
2
Refugee
2
Disability
2
Global Health Education
2
Global HIV Strategic Information Working Group
For Populations At Risk For HIV
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Prevention, early diagnosis, and effective treatment are essential for the control and elimination of Neisseria gonorrhoeae as a public health problem. Currently, in Latin America and the Caribbean, treatment for gonorrhea infection is largely empiric and based on clinical diagnosis. In the Americas...
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v...
Monkeypox is an emerging viral zoonosis with symptoms similar to those observed in smallpox patients, although less severe. Since the global eradication of smallpox in 1980, monkeypox has emerged as the most important orthopoxvirus in humans. The Advisory Committee on Variola Virus Research (ACVVR) ...
Despite the continuing war in Ukraine, the Government is preparing for the country’s recovery and reconstruction. Given the magnitude of the attacks on the health infrastructure and consequent disruption to health system functioning, reconstruction of the health system is integral to the country...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
Recency assays use one or more biomarkers to identify whether HIV infection in a person is recent (usually within a year or less) or longstanding. Recency assays have been used to estimate incidence in representative cross-sectional surveys and in epidemiological studies to better understand the pat...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards. They provide a set of recommendations th...
interim guidance, 25 November 2024
